AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10787766
Drug: All women
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All women (treatment and control)
Trial: 1289589
Drug: Cefprozil (CFPZ)
RxNorm normalized name: Cefprozil
DrugBank: Cefprozil (DB01150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefprozil (CFPZ) administered at a mean dose of 8.6 mg/kg in 3-4 divided doses for an average of 7 days.
Trial: 1289589
Drug: Cefprozil (CFPZ)
RxNorm normalized name: Cefprozil
DrugBank: Cefprozil (DB01150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefprozil (CFPZ) administered at doses of 4.0, 7.5, and 15.0 mg/kg to 9 children.
Trial: 31218077
Drug: Dimethyl fumarate
RxNorm normalized name: Dimethyl Fumarate
DrugBank: Dimethyl fumarate (DB08908)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dimethyl fumarate 240 mg
Trial: 15796146
Drug: Oral egg
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral egg albumin-based protein supplement
Trial: 12188103
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with rivastigmine
Trial: 10390227
Drug: Abacavir (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir (600 mg) alone
Trial: 10390227
Drug: Zidovudine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (300 mg) alone
Trial: 10390227
Drug: Lamivudine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine (150 mg) alone
Trial: 2005227
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid supplementation (5 mg daily)
Trial: 26713403
Drug: Denosumab (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (60 mg at baseline and 6 months)
Trial: 25918060
Drug: Conventional Medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Medical Treatment Only (MTO)
Trial: 15897671
Drug: Celecoxib (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (50 + 150 mg, cumulative dose of 200 mg)
Trial: 8965118
Drug: Copolymer 1
RxNorm normalized name: glatiramer (copolymer 1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Copolymer 1 (Copaxone), daily subcutaneous treatment, dosage not specified, duration not specified
Trial: 6848810
Drug: Amiloride-hydrochlorothiazide combination
RxNorm normalized name: amiloride / hydrochlorothiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride-hydrochlorothiazide combination
Trial: 25918718
Drug: Intravenous patient‐controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient‐controlled analgesia (PCA) with morphine (Group 1)
Trial: 18694603
Drug: Oral amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amiodarone (15 mg/Kg then 7 mg/Kg/day for one month)
Trial: 18694603
Drug: Oral bisoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bisoprolol (2.5 mg then 2.5 mg bid indefinitely)
Trial: 18694603
Drug: Oral bisoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bisoprolol
Trial: 15315305
Drug: Paclitaxel (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (90 mg/m2)
Trial: 15315305
Drug: Docetaxel (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (45 mg/m2)
Trial: 8526970
Drug: AMPT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMPT plus L-dopa/carbidopa
Trial: 8526970
Drug: L-dopa/carbidopa alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-dopa/carbidopa alone (placebo plus L-dopa/carbidopa)
Trial: 211316
Drug: Colestyramine (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestyramine (0.6 g/kg body weight)
Trial: 211316
Drug: Colestipol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol (0.5 g/kg body weight)
Trial: 25929529
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy plus general practitioners' care
Trial: 19020973
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg twice daily plus exemestane 25 mg/day
Trial: 10930365
Drug: VSL#3, 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VSL#3, 6 g/day for 9 months
Trial: 9369848
Drug: 45 mg
RxNorm normalized name: lutein 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 mg vaginal progesterone every 48 hours
Trial: 9369848
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg vaginal progesterone every 48 hours
Trial: 1339108
Drug: Less aggressive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less aggressive treatment
Trial: 3909841
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not specified what was administered)
Trial: 30795951
Drug: Denosumab (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (60 mg subcutaneously every 6 months during aromatase inhibitor therapy)
Trial: 30795951
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching placebo every 6 months during aromatase inhibitor therapy)
Trial: 26996580
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (comprehensive rehabilitation therapy only)
Trial: 21143094
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil 500 (2 g daily)
Trial: 21143094
Drug: Mycophenolate (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mycophenolate (initial dosage of 0.1 mg/kg/d)
Trial: 15911155
Drug: Morphine sulfate/dextromethorphan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine sulfate/dextromethorphan (MS/DM) combination
Trial: 8959160
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate (MS)
Trial: 15911155
Drug: Self-titrated doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-titrated doses of MS/DM
Trial: 15911155
Drug: Self-titrated doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-titrated doses of MS
Trial: 12142633
Drug: Paracetamol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1 g) during the ovulatory phase
Trial: 9449270
Drug: ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ciprofloxacin 500 mg twice daily
Trial: 7840070
Drug: Oat bran-enriched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oat bran-enriched test meal (12.8 g fiber) after 14 days of oat bran feeding (40 g/d)
Trial: 7840070
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (15.6 g fiber/d)
Trial: 1969060
Drug: Intravenous dithiocarb
RxNorm normalized name: Ditiocarb zinc
DrugBank: Ditiocarb zinc (DB14193)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dithiocarb (DTC)
Trial: 1969060
Drug: Oral dithiocarb
RxNorm normalized name: Ditiocarb zinc
DrugBank: Ditiocarb zinc (DB14193)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dithiocarb (DTC)
Trial: 1969060
Drug: DTC (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTC (both intravenous and oral)
Trial: 7433475
Drug: Oxymetazoline (formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymetazoline (formulation in boric acid)
Trial: 23560243
Drug: Buccal smear
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal smear group (259 subjects)
Trial: 16083185
Drug: Chamomile extract
RxNorm normalized name: Chamomile Extract
DrugBank: Chamomile (DB14357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamomile extract (Kamillosan M) spray, 10 puffs of total 370 mg
Trial: 16083185
Drug: Chamomile extract
RxNorm normalized name: Chamomile Extract
DrugBank: Chamomile (DB14357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamomile extract (Kamillosan M) spray
Trial: 3670972
Drug: Granulocyte transfusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte transfusions of buffy coats from single units of whole blood (0.1 to 0.9 X 10(9) polymorphonuclear leukocytes per kilogram) given daily until ANC > 1,500/microL
Trial: 23841567
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health intervention including individually tailored instructions for oral and/or denture hygiene, relief of dry mouth symptoms, decrease of sugar-use frequency, use of fluoride, xylitol or antimicrobial products, and professional tooth cleaning
Trial: 8866926
Drug: Hydroxychloroquine sulphate
RxNorm normalized name: Hydroxychloroquine sulphate
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine sulphate 200 mg orally (three tablets)
Trial: 30882150
Drug: CQ+PQ (Chloroquine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQ+PQ (Chloroquine + Primaquine: 0.25 mg base/kg/day for 14 days)
Trial: 30882150
Drug: CQ (Chloroquine:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQ (Chloroquine: 25 mg base/kg given over 3 days)
Trial: 27746233
Drug: Inulin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inulin (500 mL drink containing 40 g of inulin)
Trial: 27746233
Drug: Fructose (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructose (500 mL drink containing 40 g of fructose)
Trial: 27746233
Drug: Glucose (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (500 mL drink containing 40 g of glucose)
Trial: 26554558
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of aspirin once daily
Trial: 15468395
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine infusion via pain pump catheter for 48 hours
Trial: 15468395
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (historical patients using oral and intravenous pain medications)
Trial: 3140562
Drug: Flumazenil 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil 1.0 mg i.v. at extubation
Trial: 21205047
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy (NRT) with dose adaptation based on saliva cotinine concentrations
Trial: 21205047
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care with nicotine patches and monthly dose decreases
Trial: 16540956
Drug: ivIGMA (1300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ivIGMA (1300 mL infused intravenously within a period of 72 hrs)
Trial: 8807439
Drug: Pindolol 20
RxNorm normalized name: pindolol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 20 mg b.i.d. for 4 weeks
Trial: 8807439
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 10 mg b.i.d. for 4 weeks
Trial: 3926732
Drug: Fast neutron
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast neutron therapy (mixed neutron-photon fractionated irradiation)
Trial: 31560567
Drug: Waitlisted treatment-as-usual
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waitlisted treatment-as-usual (control) (n=18)
Trial: 31852650
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy of sepsis (Control)
Trial: 15135009
Drug: Insulin (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (0.05 IU/kg)
Trial: 15135009
Drug: Glucose (15%,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (15%, 0.5 g/kg)
Trial: 9781472
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (α-tocopherol) treatment (400-1600 IU/day)
Trial: 9781472
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (α-tocopherol) treatment
Trial: 26598177
Drug: Preoperative cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative cognitive exercise (1 hour daily for 10 days before surgery)
Trial: 21784533
Drug: Paroxetine 40
RxNorm normalized name: PARoxetine 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 40 mg/day for six weeks
Trial: 19906348
Drug: Aripiprazole 30
RxNorm normalized name: aripiprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 30 mg/d
Trial: 10904025
Drug: Icatibant (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icatibant (10 mg IV) coadministered with perindoprilat (1.5 mg IV)
Trial: 10904025
Drug: Perindoprilat (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindoprilat (1.5 mg IV)
Trial: 9519139
Drug: SPF 17
RxNorm normalized name: ZINC OXIDE 114 mg in 1 mL TOPICAL CREAM [Pacifica CC broad spectrum SPF 17 LIGHT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPF 17 broad spectrum sunscreen cream
Trial: 3030387
Drug: Perindopril 4
RxNorm normalized name: perindopril 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4 mg and over
Trial: 31731111
Drug: Fluoxetine 20
RxNorm normalized name: fluoxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20 mg by mouth daily for 90 days
Trial: 20616365
Drug: Short-range PCR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-range PCR (used in combination with TP-PCR)
Trial: 15516352
Drug: Ropivacaine 5
RxNorm normalized name: fentanyl-ropivacaine 5 mcg/mL-0.1%-0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 5 mg/ml in plain solution
Trial: 15516352
Drug: Ropivacaine 5
RxNorm normalized name: fentanyl-ropivacaine 5 mcg/mL-0.1%-0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 5 mg/ml with glucose 50 mg/ml (hyperbaric solution)
Trial: 10596996
Drug: Hepcon group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepcon group (360±80 IU/kg of heparin)
Trial: 10596996
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (300 IU/kg of heparin)
Trial: 2027802
Drug: Subcutaneous long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous long-acting epinephrine (Sus-Phrine), 0.005 ml per kg before albuterol aerosols
Trial: 2027802
Drug: Albuterol aerosols
RxNorm normalized name: Albuterol Inhalation Aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol aerosols
Trial: 7023861
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of atropine and terbutaline sulfate (0.005 mg/kg)
Trial: 7023861
Drug: Terbutaline sulfate
RxNorm normalized name: Terbutaline Sulfate
DrugBank: Terbutaline (DB00871)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terbutaline sulfate (0.005 mg/kg)
Trial: 30840136
Drug: 90 g
RxNorm normalized name: Fora G90 Glucose Test Strip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 g h-1 glucose-fructose
Trial: 30840136
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g h-1 glucose-fructose
Trial: 23858719
Drug: Specific immune
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immune therapy (SIT)
Trial: 20017325
Drug: Group psychological
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group psychological therapy for depression and anxiety during pregnancy (6 sessions, 1.5 hours each)
Trial: 20017325
Drug: Group psychological
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group psychological therapy
Trial: 15336297
Drug: Paroxetine (PAR)
DrugBank: Paroxetine (DB00715)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paroxetine (PAR) 20 mg
Trial: 15279537
Drug: 5-session Preparing
RxNorm normalized name: Caviar Preparation
DrugBank: Caviar, unspecified (DB14241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-session Preparing for the Drug Free Years Program (PDFY)
Trial: 10601133
Drug: SR49059 (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR49059 (300 mg oral dose)
Trial: 7582278
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 750 micrograms twice daily
Trial: 7582278
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 1000 micrograms twice daily
Trial: 1791718
Drug: Sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1 g, 1 tablet, 4 times a day for 20 days)
Trial: 1791718
Drug: Venter (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venter (1 g, 1 tablet, 4 times a day for 20 days)
Trial: 6972165
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (220 mg zinc sulfate twice daily for a month)
Trial: 25403296
Drug: Noofen (15‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noofen (15‐20 mg/kg, 500‐700 mg per day, perorally in 2‐3 doses)
Trial: 25403296
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of multivitamins (Control)
Trial: 16194890
Drug: Post-treatment hemoglobin
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment hemoglobin values
Trial: 20467629
Drug: Ibuprofen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (600 mg taken four times a day for one week)
Trial: 17874878
Drug: Concurrent alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent alcohol and tobacco treatment
Trial: 15564947
Drug: Probenecid (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid (500 mg)
Trial: 15564947
Drug: Quinidine (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (800 mg)
Trial: 7946872
Drug: bupivacaine 100
RxNorm normalized name: BUPivacaine 100 mg parenteral implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 100 mg and morphine 3 mg (group 3)
Trial: 7946872
Drug: bupivacaine 100
RxNorm normalized name: BUPivacaine 100 mg parenteral implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 100 mg and morphine 1 mg (group 2)
Trial: 7946872
Drug: bupivacaine 100
RxNorm normalized name: BUPivacaine 100 mg parenteral implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 100 mg (group 1)
Trial: 31999376
Drug: Denosumab 60
RxNorm normalized name: denosumab 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 60 mg subcutaneously once every 6 months for 12 to 36 months
Trial: 28182503
Drug: Glucose Nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose Nasal Spray (GLUC NAS)
Trial: 28182503
Drug: Caffeine Nasal
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine Nasal Spray (CAF NAS)
Trial: 28182503
Drug: Placebo Nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo Nasal Spray
Trial: 26142584
Drug: Sildenafil dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil dosage frequency ≤1 weekly
Trial: 26142584
Drug: Sildenafil dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil dosage frequency 2-3 weekly
Trial: 26142584
Drug: Sildenafil dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil dosage frequency 4-7 weekly
Trial: 23033239
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (mean weekly dose of 88,865 IU)
Trial: 17525774
Drug: Lidocaine 2%
RxNorm normalized name: LIDOCAINE 2% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 2% with hyaluronidase 15 IU/ml
Trial: 12660058
Drug: VIT (venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VIT (venom immunotherapy)
Trial: 8543545
Drug: Three-times-weekly, bilateral,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-times-weekly, bilateral, brief pulse ECT
Trial: 8543545
Drug: Twice-weekly ECT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly ECT plus one simulated treatment per week
Trial: 27185843
Drug: Trabectedin 1.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabectedin 1.1 mg/m² plus Doxorubicin 60 mg/m²
Trial: 27185843
Drug: Doxorubicin 75
RxNorm normalized name: DOXOrubicin 75 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 75 mg/m²
Trial: 24607844
Drug: Exercise Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise Therapy (high dose, supervised low-tech trunk exercise)
Trial: 9552779
Drug: Incisional morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incisional morphine (5 mg)
Trial: 9552779
Drug: Subcutaneous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous morphine (5 mg)